Resources

This is a simple, Excel-based tool for assessing and comparing costs of human papillomavirus (HPV) vaccination programs annually and for a period of 10 years with HPV vaccine products available in the global market.It aims to help country-level policymakers compare products and estimate vaccination program costs for different HPV vaccines, exploring multiple vaccine options at a time. The tool can be used by decision-makers, implementers, technical partners, and others in any country, whether or not the country is eligible for co-funding from Gavi, the Vaccine Alliance.Estimates of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery) are calculated separately, based on user inputs, for two perspectives: (1) the country perspective and (2) the combined country and Gavi perspective (only relevant for Gavi-eligible countries). The tool also calculates the estimated vaccine dose and cold chain volume requirements, which can support operational planning and logistics.It is important to note that cost is only one consideration when selecting an HPV vaccine product, and users involved in decision-making around new vaccine introduction or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages below. For questions or support, contact PATH's Health Economics & Outcomes Research team: HEOR@path.org.Important update as of 21 June 2023: The calculators are currently not properly calculating co-financing amounts for countries in the “accelerated transition” phase of support from Gavi, the Vaccine Alliance. We apologize for this oversight, and we are currently working with Gavi to correct this. In the meantime, please contact your Senior Country Manager at Gavi for assistance with a cost analysis rather than using the calculators.

Since 1980, PATH has been working alongside leaders, communities, and local change makers to develop sustainable systems for tackling shifting health challenges in five Southeast Asian countries. This brochure provides a synopsis of PATH's work and strategy in the region.

Billions of people have limited access to affordable and quality health products and services, despite major technological progress. An efficient market is essential for delivering health innovations to everyone who needs them. However, markets often fail those who are marginalized, poor, or affected by emergencies.PATH's Market Dynamics program works to improve health outcomes in LMICs. Our team of more than 60 staff and 50 global partners works across 24 countries and 18 projects. Together, we work to expand market access for health products and services, create solutions that strengthen local markets, and shape global agendas to build more inclusive markets.

Background: This report is a summary of the impact evaluation that was conducted with the goal of analyzing improvements in health facility supportive supervision (SS) practices after the adoption of the AfyaSS system, and use of the information in the system. AfyaSS system is a digital system that was developed through the collaboration between the Ministry of Health (MOH), president's office —regional administration and local government (PO-RALG), PATH and other stakeholders. The AfyaSS system aims to improve the management and use of health facility supervision data for better health service delivery in Tanzania. It also supports continuity in tracking performance and ensures that better quality data is available and used in managing supervisions.Objective: The objective of conducting this impact evaluation was to assess the improvement in supportive supervision practices after the implementation of the AfyaSS system.Method: A multi-case study approach was adopted where both qualitative and quantitative data were collected. The purpose was to get the breadth and depth of findings from a wide range of respondents. A purposive sampling method was used in recruiting participants for the assessment. The main data collection methods used to gather findings of the qualitative approach were key informant interviews (KIIs), observation, artifact analysis, and document review, while data collection for the quantitative approach consisted of online questionnaires. The baseline assessment was conducted from June 6 through August 10, 2021, where a total of 88 interviews were conducted, and 501 online survey responses were gathered. For endline, data collection was conducted from August 1 – 17, 2022 where a total of 100 KIIs were conducted, and 620 survey responses were gathered.Findings: Generally, the assessment indicated improved data use through real time access of previous supervision reports and plans. Both baseline and endline assessments showed participation of the entire team of supervisors and better coordination was noted as well, when organizing supportive supervision using AfyaSS system. Furthermore, the AfyaSS system had promoted accountability as the system requires the supervisors' and supervisees' signatures upon completion of supervision visit, and capturing start and end time of the visit, as well as GPS location where the supervision was conducted. The findings further show that the 6 councils that received training from the DUP implementation team documented more planned supervision trips (N=589), compared to those which did not receive training (N=86) from the DUP implementation team. The main challenge noted by this study was untimely supervision visits, delay, or non-delivery of feedback reports to the health facilities from supervisors.

There has been noteworthy progress in reducing maternal and child mortality in past decade. Focus needs to shift to equity and innovation gaps that need to be addressed to further improve MNCH outcomes. Under project Saksham, partners are working together to boost implementation of high-impact interventions in three Indian states- Assam, Chhattisgarh, and Odisha that have high-burden of maternal, newborn and child morbidity and mortality. We work towards improving access to quality MNCH services leveraging blend of expertise in capacity building, private providers engagement, industry leverage and community participation to harness a total market approach for maximum impact.